Announcements Trials

Browse Landscape

Phase

Phase 2 6 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 725 Lymphoma, Non-Hodgkin 657 Precursor Cell Lymphoblastic Leukemia-Lymphoma 583 Leukemia, Lymphocytic, Chronic, B-Cell 555 Lymphoma, Large B-Cell, Diffuse 440 Lymphoma, Follicular 418 Lymphoma, Mantle-Cell 345 Burkitt Lymphoma 306 Leukemia 303 Leukemia, Myeloid, Acute 297 Hodgkin Disease 293 Lymphoma, B-Cell 280 Lymphoma, B-Cell, Marginal Zone 267 Recurrence 246 Multiple Myeloma 205 Neoplasms 199 Lymphoma, T-Cell, Cutaneous 171 Myelodysplastic Syndromes 170 Lymphoma, Large-Cell, Immunoblastic 160 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 159 Waldenstrom Macroglobulinemia 146 Lymphoma, Large-Cell, Anaplastic 142 Mycosis Fungoides 132 Sezary Syndrome 119 Immunoblastic Lymphadenopathy 108 Blast Crisis 92 Hematologic Neoplasms 91 Lymphoma, T-Cell, Peripheral 86 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 86 Lymphoma, T-Cell 82

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aggression × Lymphoid × Clear all

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡